Bay Street News, September, 2020

NEW YORK, Sept. 21, 2020 (GLOBE NEWSWIRE) — The Nasdaq Stock Market announced today that it will delist the American Depositary Shares, […]

New analysis of age-related macular degeneration (AMD) progression in Phase 2 FILLY study accepted as late-breaking oral presentation at European […]

SILVER SPRING, Md., Sept. 21, 2020 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (“Aziyo”), a commercial-stage regenerative medicine company focused on […]

SUNNYVALE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk […]

WALTHAM, Mass., Sept. 21, 2020 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing […]

Encouraging Efficacy Signals Observed in Heavily Pre-Treated Patients with Metastatic Colorectal Cancer in the Phase Ib Study of NUC-3373 (NuTide:302)NUC-3373’s […]

SINGAPORE, Sept. 21, 2020 (GLOBE NEWSWIRE) — Grindrod Shipping Holdings Ltd. (NASDAQ: GRIN) (JSE: GSH) (“Grindrod Shipping” or “Company” or […]

IRVINE, Calif., Sept. 21, 2020 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused […]

TAMPA, Fla., Sept. 21, 2020 (GLOBE NEWSWIRE) — Kforce Inc. (NASDAQ: KFRC) today provided an update to its expected third […]

TEL AVIV, Israel, Sept. 21, 2020 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the […]